Image:
Credit: AstraZeneca
Pharmaceuticals giant claims its respiratory medicine can be used in a new climate friendly inhaler that promises 'near-zero global warming potential'
One of the healthcare sectors largest sources of greenhouse gas emissions could soon be tackled, after AstraZeneca secured regulatory approval in the UK for the use of respiratory medicine in its climate...
To continue reading this article...
Join BusinessGreen
In just a few clicks you can start your free BusinessGreen Lite membership for 12 months, providing you access to:
- Three complimentary articles per month covering the latest real-time news, analysis, and opinion from Europe’s leading source of information on the Green economy and business
- Receive important and breaking news stories via our daily news alert
- Our weekly newsletter with the best of the week’s green business news and analysis
